According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Cerebrovascular Disease Market

Cerebrovascular diseases are a group of condition characterized by a certain dysfunction of blood vessels supplying the brain and also affect the flow of blood in an individual’s brain. For proper functioning of the brain, it needs certain nutrients and oxygen from the arteries. However, if there is any kind of restriction in the blood flow, the brain cells begin to die. The prime causes of cerebrovascular disease are cerebral thrombosis, cerebral embolism, and cerebral hemorrhage. Due to cerebrovascular disease, part of the brain is affected due to bleeding and thereby leads to different types of cerebrovascular diseases such as stroke, transient ischaemic attack (TIA), vascular dementia, and subarachnoid hemorrhage.

The global Cerebrovascular Disease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Cerebrovascular Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cerebrovascular Disease.

Report Scope

The Cerebrovascular Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cerebrovascular Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cerebrovascular Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cerebrovascular Disease Market Report

Report Metric	Details
Report Name	Cerebrovascular Disease Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	Carotid Endarterectomy Carotid Angioplasty Or Carotid Artery Stenting Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
Segment by Application	Academic & Research Institutes Pharmaceutical & Biotechnology Companies Hospitals & Diagnostic Centers Contract Research Organizations Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson & Johnson, Amgen, GlaxoSmithKline, Sanofi-Aventis, Merck, Sangamo BioSciences, Aldagen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cerebrovascular Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cerebrovascular Disease Market report?

Ans: The main players in the Cerebrovascular Disease Market are Johnson & Johnson, Amgen, GlaxoSmithKline, Sanofi-Aventis, Merck, Sangamo BioSciences, Aldagen

What are the Application segmentation covered in the Cerebrovascular Disease Market report?

Ans: The Applications covered in the Cerebrovascular Disease Market report are Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers, Contract Research Organizations, Others

What are the Type segmentation covered in the Cerebrovascular Disease Market report?

Ans: The Types covered in the Cerebrovascular Disease Market report are Carotid Endarterectomy, Carotid Angioplasty Or Carotid Artery Stenting, Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cerebrovascular Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Carotid Endarterectomy

1.2.3 Carotid Angioplasty Or Carotid Artery Stenting

1.2.4 Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)

1.3 Market by Application

1.3.1 Global Cerebrovascular Disease Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Academic & Research Institutes

1.3.3 Pharmaceutical & Biotechnology Companies

1.3.4 Hospitals & Diagnostic Centers

1.3.5 Contract Research Organizations

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cerebrovascular Disease Market Perspective (2019-2030)

2.2 Cerebrovascular Disease Growth Trends by Region

2.2.1 Global Cerebrovascular Disease Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cerebrovascular Disease Historic Market Size by Region (2019-2024)

2.2.3 Cerebrovascular Disease Forecasted Market Size by Region (2025-2030)

2.3 Cerebrovascular Disease Market Dynamics

2.3.1 Cerebrovascular Disease Industry Trends

2.3.2 Cerebrovascular Disease Market Drivers

2.3.3 Cerebrovascular Disease Market Challenges

2.3.4 Cerebrovascular Disease Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cerebrovascular Disease Players by Revenue

3.1.1 Global Top Cerebrovascular Disease Players by Revenue (2019-2024)

3.1.2 Global Cerebrovascular Disease Revenue Market Share by Players (2019-2024)

3.2 Global Cerebrovascular Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cerebrovascular Disease Revenue

3.4 Global Cerebrovascular Disease Market Concentration Ratio

3.4.1 Global Cerebrovascular Disease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cerebrovascular Disease Revenue in 2023

3.5 Cerebrovascular Disease Key Players Head office and Area Served

3.6 Key Players Cerebrovascular Disease Product Solution and Service

3.7 Date of Enter into Cerebrovascular Disease Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Cerebrovascular Disease Breakdown Data by Type

4.1 Global Cerebrovascular Disease Historic Market Size by Type (2019-2024)

4.2 Global Cerebrovascular Disease Forecasted Market Size by Type (2025-2030)

5 Cerebrovascular Disease Breakdown Data by Application

5.1 Global Cerebrovascular Disease Historic Market Size by Application (2019-2024)

5.2 Global Cerebrovascular Disease Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cerebrovascular Disease Market Size (2019-2030)

6.2 North America Cerebrovascular Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cerebrovascular Disease Market Size by Country (2019-2024)

6.4 North America Cerebrovascular Disease Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cerebrovascular Disease Market Size (2019-2030)

7.2 Europe Cerebrovascular Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cerebrovascular Disease Market Size by Country (2019-2024)

7.4 Europe Cerebrovascular Disease Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cerebrovascular Disease Market Size (2019-2030)

8.2 Asia-Pacific Cerebrovascular Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cerebrovascular Disease Market Size by Region (2019-2024)

8.4 Asia-Pacific Cerebrovascular Disease Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cerebrovascular Disease Market Size (2019-2030)

9.2 Latin America Cerebrovascular Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cerebrovascular Disease Market Size by Country (2019-2024)

9.4 Latin America Cerebrovascular Disease Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cerebrovascular Disease Market Size (2019-2030)

10.2 Middle East & Africa Cerebrovascular Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cerebrovascular Disease Market Size by Country (2019-2024)

10.4 Middle East & Africa Cerebrovascular Disease Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Johnson & Johnson

11.1.1 Johnson & Johnson Company Detail

11.1.2 Johnson & Johnson Business Overview

11.1.3 Johnson & Johnson Cerebrovascular Disease Introduction

11.1.4 Johnson & Johnson Revenue in Cerebrovascular Disease Business (2019-2024)

11.1.5 Johnson & Johnson Recent Development

11.2 Amgen

11.2.1 Amgen Company Detail

11.2.2 Amgen Business Overview

11.2.3 Amgen Cerebrovascular Disease Introduction

11.2.4 Amgen Revenue in Cerebrovascular Disease Business (2019-2024)

11.2.5 Amgen Recent Development

11.3 GlaxoSmithKline

11.3.1 GlaxoSmithKline Company Detail

11.3.2 GlaxoSmithKline Business Overview

11.3.3 GlaxoSmithKline Cerebrovascular Disease Introduction

11.3.4 GlaxoSmithKline Revenue in Cerebrovascular Disease Business (2019-2024)

11.3.5 GlaxoSmithKline Recent Development

11.4 Sanofi-Aventis

11.4.1 Sanofi-Aventis Company Detail

11.4.2 Sanofi-Aventis Business Overview

11.4.3 Sanofi-Aventis Cerebrovascular Disease Introduction

11.4.4 Sanofi-Aventis Revenue in Cerebrovascular Disease Business (2019-2024)

11.4.5 Sanofi-Aventis Recent Development

11.5 Merck

11.5.1 Merck Company Detail

11.5.2 Merck Business Overview

11.5.3 Merck Cerebrovascular Disease Introduction

11.5.4 Merck Revenue in Cerebrovascular Disease Business (2019-2024)

11.5.5 Merck Recent Development

11.6 Sangamo BioSciences

11.6.1 Sangamo BioSciences Company Detail

11.6.2 Sangamo BioSciences Business Overview

11.6.3 Sangamo BioSciences Cerebrovascular Disease Introduction

11.6.4 Sangamo BioSciences Revenue in Cerebrovascular Disease Business (2019-2024)

11.6.5 Sangamo BioSciences Recent Development

11.7 Aldagen

11.7.1 Aldagen Company Detail

11.7.2 Aldagen Business Overview

11.7.3 Aldagen Cerebrovascular Disease Introduction

11.7.4 Aldagen Revenue in Cerebrovascular Disease Business (2019-2024)

11.7.5 Aldagen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Cerebrovascular Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Carotid Endarterectomy

Table 3. Key Players of Carotid Angioplasty Or Carotid Artery Stenting

Table 4. Key Players of Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)

Table 5. Global Cerebrovascular Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Cerebrovascular Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Cerebrovascular Disease Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Cerebrovascular Disease Market Share by Region (2019-2024)

Table 9. Global Cerebrovascular Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Cerebrovascular Disease Market Share by Region (2025-2030)

Table 11. Cerebrovascular Disease Market Trends

Table 12. Cerebrovascular Disease Market Drivers

Table 13. Cerebrovascular Disease Market Challenges

Table 14. Cerebrovascular Disease Market Restraints

Table 15. Global Cerebrovascular Disease Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Cerebrovascular Disease Market Share by Players (2019-2024)

Table 17. Global Top Cerebrovascular Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cerebrovascular Disease as of 2023)

Table 18. Ranking of Global Top Cerebrovascular Disease Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Cerebrovascular Disease Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Cerebrovascular Disease Product Solution and Service

Table 22. Date of Enter into Cerebrovascular Disease Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Cerebrovascular Disease Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Cerebrovascular Disease Revenue Market Share by Type (2019-2024)

Table 26. Global Cerebrovascular Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Cerebrovascular Disease Revenue Market Share by Type (2025-2030)

Table 28. Global Cerebrovascular Disease Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Cerebrovascular Disease Revenue Market Share by Application (2019-2024)

Table 30. Global Cerebrovascular Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Cerebrovascular Disease Revenue Market Share by Application (2025-2030)

Table 32. North America Cerebrovascular Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Cerebrovascular Disease Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Cerebrovascular Disease Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Cerebrovascular Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Cerebrovascular Disease Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Cerebrovascular Disease Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Cerebrovascular Disease Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Cerebrovascular Disease Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Cerebrovascular Disease Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Cerebrovascular Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Cerebrovascular Disease Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Cerebrovascular Disease Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Cerebrovascular Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Cerebrovascular Disease Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Cerebrovascular Disease Market Size by Country (2025-2030) & (US$ Million)

Table 47. Johnson & Johnson Company Detail

Table 48. Johnson & Johnson Business Overview

Table 49. Johnson & Johnson Cerebrovascular Disease Product

Table 50. Johnson & Johnson Revenue in Cerebrovascular Disease Business (2019-2024) & (US$ Million)

Table 51. Johnson & Johnson Recent Development

Table 52. Amgen Company Detail

Table 53. Amgen Business Overview

Table 54. Amgen Cerebrovascular Disease Product

Table 55. Amgen Revenue in Cerebrovascular Disease Business (2019-2024) & (US$ Million)

Table 56. Amgen Recent Development

Table 57. GlaxoSmithKline Company Detail

Table 58. GlaxoSmithKline Business Overview

Table 59. GlaxoSmithKline Cerebrovascular Disease Product

Table 60. GlaxoSmithKline Revenue in Cerebrovascular Disease Business (2019-2024) & (US$ Million)

Table 61. GlaxoSmithKline Recent Development

Table 62. Sanofi-Aventis Company Detail

Table 63. Sanofi-Aventis Business Overview

Table 64. Sanofi-Aventis Cerebrovascular Disease Product

Table 65. Sanofi-Aventis Revenue in Cerebrovascular Disease Business (2019-2024) & (US$ Million)

Table 66. Sanofi-Aventis Recent Development

Table 67. Merck Company Detail

Table 68. Merck Business Overview

Table 69. Merck Cerebrovascular Disease Product

Table 70. Merck Revenue in Cerebrovascular Disease Business (2019-2024) & (US$ Million)

Table 71. Merck Recent Development

Table 72. Sangamo BioSciences Company Detail

Table 73. Sangamo BioSciences Business Overview

Table 74. Sangamo BioSciences Cerebrovascular Disease Product

Table 75. Sangamo BioSciences Revenue in Cerebrovascular Disease Business (2019-2024) & (US$ Million)

Table 76. Sangamo BioSciences Recent Development

Table 77. Aldagen Company Detail

Table 78. Aldagen Business Overview

Table 79. Aldagen Cerebrovascular Disease Product

Table 80. Aldagen Revenue in Cerebrovascular Disease Business (2019-2024) & (US$ Million)

Table 81. Aldagen Recent Development

Table 82. Research Programs/Design for This Report

Table 83. Key Data Information from Secondary Sources

Table 84. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cerebrovascular Disease Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Cerebrovascular Disease Market Share by Type: 2023 VS 2030

Figure 3. Carotid Endarterectomy Features

Figure 4. Carotid Angioplasty Or Carotid Artery Stenting Features

Figure 5. Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) Features

Figure 6. Global Cerebrovascular Disease Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Cerebrovascular Disease Market Share by Application: 2023 VS 2030

Figure 8. Academic & Research Institutes Case Studies

Figure 9. Pharmaceutical & Biotechnology Companies Case Studies

Figure 10. Hospitals & Diagnostic Centers Case Studies

Figure 11. Contract Research Organizations Case Studies

Figure 12. Others Case Studies

Figure 13. Cerebrovascular Disease Report Years Considered

Figure 14. Global Cerebrovascular Disease Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Cerebrovascular Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Cerebrovascular Disease Market Share by Region: 2023 VS 2030

Figure 17. Global Cerebrovascular Disease Market Share by Players in 2023

Figure 18. Global Top Cerebrovascular Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cerebrovascular Disease as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Cerebrovascular Disease Revenue in 2023

Figure 20. North America Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Cerebrovascular Disease Market Share by Country (2019-2030)

Figure 22. United States Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Cerebrovascular Disease Market Share by Country (2019-2030)

Figure 26. Germany Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Cerebrovascular Disease Market Share by Region (2019-2030)

Figure 34. China Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Cerebrovascular Disease Market Share by Country (2019-2030)

Figure 42. Mexico Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Cerebrovascular Disease Market Share by Country (2019-2030)

Figure 46. Turkey Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Cerebrovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Johnson & Johnson Revenue Growth Rate in Cerebrovascular Disease Business (2019-2024)

Figure 49. Amgen Revenue Growth Rate in Cerebrovascular Disease Business (2019-2024)

Figure 50. GlaxoSmithKline Revenue Growth Rate in Cerebrovascular Disease Business (2019-2024)

Figure 51. Sanofi-Aventis Revenue Growth Rate in Cerebrovascular Disease Business (2019-2024)

Figure 52. Merck Revenue Growth Rate in Cerebrovascular Disease Business (2019-2024)

Figure 53. Sangamo BioSciences Revenue Growth Rate in Cerebrovascular Disease Business (2019-2024)

Figure 54. Aldagen Revenue Growth Rate in Cerebrovascular Disease Business (2019-2024)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Cerebral Palsy Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36K2790

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Chorea Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-22U5801

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Amyotrophic Lateral Sclerosis (ALS) Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-17W2541

Sun Apr 07 00:00:00 UTC 2024

Add to Cart

Parkinson Disease Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-39X2260

Sun Apr 07 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions